Literature DB >> 11569682

The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease.

N L Arents1, A A van Zwet, J C Thijs, A M Kooistra-Smid, K R van Slochteren, J E Degener, J H Kleibeuker, L J van Doorn.   

Abstract

OBJECTIVE: To study the relationship between the presence of H. pylori virulence factors and clinical outcome in H. pylori infected patients.
METHODS: DNA was isolated from an antral biopsy sample and vacA, cagA, and iceA genotype were determined by PCR and a reverse hybridization technique in 183 patients with culture-proven H. pylori infection: 51 with peptic ulcer disease (PUD), 62 with gastroesophageal reflux disease (GERD), and 70 with a normal endoscopy (gastritis only; GO).
RESULTS: Forty-four samples (24%) showed more than one allelic variant in the vacA s- or in-region and/or both iceA1 and iceA2 genotypes, indicating multiple strain infection. These were excluded from statistical analysis. vacA s1 and cagA were significantly more common in PUD than in GERD and GO. Logistic regression analysis showed that GERD patients were more often infected with strains lacking both cagA and iceA than GO patients (OR = 0.36; CI = 0.15-0.89). Trend analysis showed that GERD patients were most often infected with less virulent strains (p < 0.002).
CONCLUSION: Multiple strain infection is common. H. pylori strains possessing the vacA s1 genotype and/or cagA are associated with PUD. GERD patients, infected with H. pylori, mostly carry less virulent strains possessing neither cagA nor iceA1. Our findings support the hypothesis that virulent strains protect against the development of GERD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11569682     DOI: 10.1111/j.1572-0241.2001.04104.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran.

Authors:  Abbas Yadegar; Ashraf Mohabati Mobarez; Masoud Alebouyeh; Tabassom Mirzaei; Terry Kwok; Mohammad Reza Zali
Journal:  World J Microbiol Biotechnol       Date:  2014-05-23       Impact factor: 3.312

Review 2.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  ITGA1 polymorphisms and haplotypes are associated with gastric cancer risk in a Korean population.

Authors:  Dong-Hyuk Yim; Yan-Wei Zhang; Sang-Yong Eom; Sun In Moon; Hyo-Yung Yun; Young-Jin Song; Sei-Jin Youn; Taisun Hyun; Joo-Seung Park; Byung Sik Kim; Jong-Young Lee; Yong-Dae Kim; Heon Kim
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

4.  Molecular Basis of pathogenicity in Helicobacter pylori clinical isolates.

Authors:  Ivy Bastos Ramis; Tesiê Leopoldo Fonseca; Ernani Pinho de Moraes; Márcia Silveira Fernandes; Raul Mendoza-Sassi; Obirajara Rodrigues; Carlos Renan Varela Juliano; Carlos James Scaini; Pedro Eduardo Almeida da Silva
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

5.  Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes.

Authors:  Yan-Wing Ho; Khek-Yu Ho; Felipe Ascencio; Bow Ho
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori.

Authors:  Feng-Chan Han; Han-Chong Ng; Bow Ho
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey.

Authors:  Huseyin Saribasak; Barik A Salih; Yoshio Yamaoka; Ersan Sander
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura.

Authors:  Yanyan Bai; Zhaoyue Wang; Xia Bai; Ziqiang Yu; Lijuan Cao; Wei Zhang; Changgeng Ruan
Journal:  Int J Hematol       Date:  2009-01-30       Impact factor: 2.490

9.  Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease.

Authors:  Nawfal R Hussein; Marjan Mohammadi; Yeganeh Talebkhan; Masoumeh Doraghi; Darren P Letley; Merdan K Muhammad; Richard H Argent; John C Atherton
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

10.  Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells.

Authors:  Andrew D Jones; Kathy D Bacon; Blair A Jobe; Brett C Sheppard; Clifford W Deveney; Michael J Rutten
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.